Evaluation of Fetal Sex in Assisted Reproductive Technology (ART) Achieved Pregnancies

Completed

Conditions studied: Fetal Sex Determination

In brief

Whole blood and urine samples will be collected from pregnant woman of gestational age 36-56 days as confirmed by artificial reproductive technology (ART). The samples will be used to develop a prenatal sex test using circulating cell free fetal DNA (ccffDNA) in maternal plasma or urine.

Key facts

Study ID

NCT01021085

Run by

Sequenom, Inc.

People needed

500

Starts

2009-04-01

Expected to finish

2011-09-01

Last updated by the study team

2011-09-05

Who can join

Age: 18 and older, up to 45. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Subject is 18-45 years of age inclusive
• Subject is female
• Subject is pregnant
• Gestational age can be determined via IVF or IUI
• Subject is 36-42 days pregnant as determined by IVF transfer or IUI
• Subject agrees to provide 3 separate blood and urine samples

You may not qualify if…

• None

Where it is running

• San Diego Fertility Center — San Diego, California, United States
• Fertility Centers of Illinois — Glenview, Illinois, United States
• Fertility Center of Las Vegas — Las Vegas, Nevada, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.